Twist Bioscience, Artisan Development Labs partner to discover cell therapies
Twist Bioscience has teamed up with Artisan Development Labs to discover new antibodies against five undisclosed targets.
January 26, 2022
by pharmaceutical-business-review.
Twist Bioscience launches new company for Covid-19 antibody treatments
Twist Bioscience has announced the formation of an independently operated biotechnology company, Revelar Biotherapeutics, which will develop and market new Covid-19 and other antibody therapies...
November 17, 2021
by Pharmaceutical-Technology
Twist Alliance Pan-Cancer Methylation Panel Global Launch Event - A Strategic Collaboration Between AnchorDx and Twist Bioscience for Pan-Cancer Liquid Biopsy
The Twist Alliance Pan-Cancer Methylation Panel (Pan-Cancer Panel), a solution for pan-cancer study including DNA methylation library preparation and targeted enrichment for next-generation sequencing (NGS)...
October 13, 2021
by prnasia
Twist Bioscience announces potent SARS-CoV-2 neutralising data from Covid-19 therapeutic antibody programme
Twist Bioscience announced data demonstrating the potent neutralizing effects of multiple potential therapeutic antibodies, both Immunoglobulin G (IgG) antibodies and substantially smaller single domain VHH “nanobodies,” against SARS-CoV-2, the virus ...
September 8, 2020
by pharmaceutical-business-review
Seismic Bio partners with Twist Bioscience for discovery and optimisation of antibodies
Twist Bioscience Corporation and Seismic Bio announced a partnership for the discovery and optimization of antibodies to high-value immuno-oncology targets.
August 7, 2020
by pharmaceutical-business-review
Twist Bioscience identifies competitive antibodies for SARS-CoV-2
Twist Bioscience reported it has identified competitive antibodies to SARS-CoV-2, the virus that causes COVID-19, which could potentially be used for diagnostic tests or therapeutic treatments.
May 11, 2020
by pharmaceutical-business-review
Twist Bioscience announces strategic collaboration with Schrödinger for drug discovery
Twist Bioscience, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced a collaboration with Schrödinger, a company focused on transforming the way therapeutics are discovered with
January 19, 2020
by pharmaceutical-business-review
Twist Bioscience, LakePharma Form Collaboration
Twist Bioscience, LakePharma Form Collaboration
April 9, 2019
by contractpharma